Shots:

• Cognoa partnered with ALP to provide its screening app to the parents that help in assessing their child's developmental progress including gross motor skills and social-emotional development of the child
• Cognoa’s app allows ALP clinicians to identify children at risk for ASD and direct them to expedited diagnostic evaluation ensuring that children receive ABA therapy services when required
• The companies collaborated to address the need of patients with innovative and clinically validated technology for identifying children at risk for ASD. Cognoa’s digital therapies promote neuromodulation of brain networks leading to an improvement in functional connectivity for lifelong gains

Click here ­to­ read full press release/ article | Ref: GlobeNewswire | Image: Marjanzamanian